Cargando…
Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
A 51-year-old man was admitted due to an acute anterior ST-segment elevation myocardial infarction. After thrombolytic therapy using recombinant tissue plasminogen activator, stent implantation was performed from the proximal left anterior descending artery (LAD) to the mid LAD using a bare-metal st...
Autores principales: | Hachinohe, Daisuke, Jeong, Myung Ho, Kim, Min Chol, Cho, Kyung Hoon, Ahmed, Khurshid, Hwang, Seung Hwan, Lee, Min Goo, Sim, Doo Sun, Park, Keun-Ho, Kim, Ju Han, Hong, Young Joon, Ahn, Youngkeun, Kang, Jung Chaee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242025/ https://www.ncbi.nlm.nih.gov/pubmed/22194765 http://dx.doi.org/10.4070/kcj.2011.41.11.677 |
Ejemplares similares
-
Intravascular Ultrasound-Guided Treatment for In-stent Restenosis Associated with Stent Fracture in Overlapped Drug-eluting Stents
por: Kim, Min Chul, et al.
Publicado: (2019) -
Very Late Stent Thrombosis due to Neointimal Rupture After Paclitaxel-Eluting Stent Implantation
por: Kee, Won Ju, et al.
Publicado: (2011) -
Effect of Atorvastatin-Eluting Stents in a Rabbit Iliac Artery Restenosis Model
por: Lim, Kyung Seob, et al.
Publicado: (2013) -
Histopathological Comparison among Biolimus, Zotarolimus and Everolimus-Eluting Stents in Porcine Coronary Restenosis Model
por: Lim, Kyung Seob, et al.
Publicado: (2013) -
Effect of a Dual Drug-Coated Stent With Abciximab and Alpha-Lipoic Acid in a Porcine Coronary Restenosis Model
por: Lim, Kyung Seob, et al.
Publicado: (2011)